Sign in
Not yet recruitingPhase 4

Zoledronic acid compared with placebo for hip osteoarthritis

Tests zoledronic acid against placebo in adults with hip osteoarthritis.

Key facts

Who runs it
Martina Hansens Hospital AS
Where
Norway1 site in 1 countryChoose a country to see its sites
Registry title
A randomized placebo controlled trial testing the effect of Zoledronic Acid on Hip osteoarthritis
Status
Not yet recruiting
Phase
Phase 4
People taking part
70 people, planned
Started
28 Apr 2025
Planned end
30 Jun 2026
Type of study
Interventional
Record updated
15 May 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with osteoarthritis of the hip. It tests Zoledronic Acid against a placebo (a dummy treatment).

Age
18 Years and older
Sex
All sexes
Disease stage
Osteoarthritis of the hip

Main reasons for not taking part

  • Healthy volunteers cannot join

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
Zoledronic acid compared with placebo for hip osteoarthritisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
15 May 2025